NCT07722546 · Interventional trial
A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
Overall registry status Recruiting
Phase 2
Conditions Graves' Disease
Delaware Valley sites
- Bioluminux Clinical Research · Hamilton, NJ · Mercer County · Recruiting
First posted
Registry updated
Added to the directory